Impact of Different Doses of Omega-3 Fatty Acids on Cardiovascular Outcomes: a Pairwise and Network Meta-analysis

Current Atherosclerosis Reports
Marco LombardiDave L Dixon

Abstract

Omega-3 fatty acid (O3FA) supplementation has shown conflicting evidence regarding its benefit in cardiovascular events. We performed a pairwise and network meta-analysis to elucidate the benefit of different doses of O3FA supplementation in cardiovascular prevention. Fourteen studies were identified providing data on 125,763 patients. A prespecified cut-off value of < 1 g per day was set for low-dose (LD) O3FA and > 1 g per day for high-dose (HD) O3FA. The efficacy outcomes of interest were total death, cardiac death, sudden cardiac death, myocardial infarction, stroke, coronary revascularization, unstable angina, and major vascular events. Safety outcomes of interest were bleeding, gastrointestinal disturbances, and atrial fibrillation events. HD treatment was associated with a lower risk of cardiac death (IRR 0.79, 95% CI [0.65-0.96], p = 0.03 versus control), myocardial infarction (0.71 [0.62-0.82], p < 0.0001 versus control and 0.79 [0.67-0.92], p = 0.003 versus LD), coronary revascularization (0.74 [0.66-0.83], p < 0.0001 versus control and 0.74 [0.66-0.84], p < 0.0001 versus LD), unstable angina (0.73 [0.62-0.86], p = 0.0001 versus control and 0.74 [0.62-0.89], p = 0.002 versus LD), and major vascular events (0.78 [0.71-...Continue Reading

References

Apr 10, 2004·BMJ : British Medical Journal·R Brian Haynes, Nancy L Wilczynski
Apr 3, 2007·Lancet·Mitsuhiro YokoyamaUNKNOWN Japan EPA lipid intervention study (JELIS) Investigators
Apr 15, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Gunnar EinvikElsa M Hjerkinn
Jul 20, 2010·Lancet·Palaniappan SaravananPhilip C Calder
Dec 1, 2010·BMJ : British Medical Journal·Pilar GalanUNKNOWN SU.FOL.OM3 Collaborative Group
Mar 4, 2011·The New England Journal of Medicine·Eddie VosDominique Lanzmann-Petithory
Jun 13, 2012·The New England Journal of Medicine·Jackie BoschSalim Yusuf
Apr 19, 2013·Current Opinion in Lipidology·Chuchun L Chang, Richard J Deckelbaum
May 10, 2013·The New England Journal of Medicine·UNKNOWN Risk and Prevention Study Collaborative GroupRoberto Marchioli
Jun 18, 2017·Circulation·Frank M SacksUNKNOWN American Heart Association
Feb 10, 2018·International Journal of Molecular Sciences·Jacqueline K Innes, Philip C Calder
Mar 25, 2018·Progress in Cardiovascular Diseases·Andrew ElagiziRichard V Milani
May 12, 2018·Circulation Research·Michael D ShapiroSergio Fazio
Aug 28, 2018·The New England Journal of Medicine·UNKNOWN ASCEND Study Collaborative GroupJane Armitage
Nov 13, 2018·The New England Journal of Medicine·Deepak L BhattUNKNOWN REDUCE-IT Investigators
Nov 13, 2018·The New England Journal of Medicine·JoAnn E MansonUNKNOWN VITAL Research Group
Aug 10, 2019·The American Journal of Clinical Nutrition·Rachel E WalkerWilliam S Harris
Aug 14, 2019·Journal of Pharmacy Practice·Barbara S WigginsRebecca Tran
Aug 30, 2019·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins
Sep 11, 2019·European Heart Journal·François MachUNKNOWN ESC Scientific Document Group
Sep 29, 2019·Journal of the American College of Cardiology·Dave L DixonSalim S Virani
Nov 2, 2019·Progress in Cardiovascular Diseases·William S Harris
Nov 13, 2019·Progress in Cardiovascular Diseases·Vera Bittner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.